Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements
Open Access
- 15 September 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Annals of Intensive Care
- Vol. 11 (1), 1-11
- https://doi.org/10.1186/s13613-021-00923-4
Abstract
Invasive pulmonary aspergillosis (IPA) has always been a challenging diagnosis and risk factors an important guide to investigate specific population, especially in Intensive Care Unit. Traditionally recognized risk factors for IPA have been haematological diseases or condition associated with severe immunosuppression, lately completed by chronic conditions (such as obstructive pulmonary disease, liver cirrhosis, chronic kidney disease and diabetes), influenza infection and Intensive Care Unit (ICU) admission. Recently, a new association with SARS-CoV2 infection, named COVID-19-associated pulmonary aspergillosis (CAPA), has been reported worldwide, even if its basic epidemiological characteristics have not been completely established yet. In this narrative review, we aimed to explore the potential risk factors for the development of CAPA and to evaluate whether previous host factors or therapeutic approaches used in the treatment of COVID-19 critically ill patients (such as mechanical ventilation, intensive care management, corticosteroids, broad-spectrum antibiotics, immunomodulatory agents) may impact this new diagnostic category. Reviewing all English-language articles published from December 2019 to December 2020, we identified 21 papers describing risk factors, concerning host comorbidities, ICU management, and COVID-19 therapies. Although limited by the quality of the available literature, data seem to confirm the role of previous host risk factors, especially respiratory diseases. However, the attention is shifting from patients’ related risk factors to factors characterizing the hospital and intensive care course, deeply influenced by specific features of COVID treatment itself. Prolonged invasive or non-invasive respiratory support, as well as the impact of corticosteroids and/or immunobiological therapies seem to play a pivotal role. ICU setting related factors, such as environmental factors, isolation conditions, ventilation systems, building renovation works, and temporal spread with respect to pandemic waves, need to be considered. Large, prospective studies based on new risk factors specific for CAPA are warranted to guide surveillance and decision of when and how to treat this particular population.Keywords
This publication has 59 references indexed in Scilit:
- Smoking as a Risk Factor of Invasive Fungal Disease: Systematic Review and Meta-AnalysisClinical Infectious Diseases, 2020
- Acute kidney injury in burn patients admitted to the intensive care unit: a systematic review and meta-analysisCritical Care, 2020
- Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research ConsortiumClinical Infectious Diseases, 2019
- Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort studyThe Lancet Respiratory Medicine, 2018
- Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomesCritical Care, 2015
- Diminished adrenal sensitivity to endogenous and exogenous adrenocorticotropic hormone in critical illness: a prospective cohort studyCritical Care, 2015
- Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective studyIntensive Care Medicine, 2012
- A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill PatientsAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Clinical risk factors for invasive aspergillosisMedical Mycology, 2011
- Invasive Aspergillosis in the Intensive Care UnitClinical Infectious Diseases, 2007